Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA; email:
Annu Rev Biochem. 2018 Jun 20;87:783-807. doi: 10.1146/annurev-biochem-062917-011852. Epub 2017 Aug 25.
Scap is a polytopic membrane protein that functions as a molecular machine to control the cholesterol content of membranes in mammalian cells. In the 21 years since our laboratory discovered Scap, we have learned how it binds sterol regulatory element-binding proteins (SREBPs) and transports them from the endoplasmic reticulum (ER) to the Golgi for proteolytic processing. Proteolysis releases the SREBP transcription factor domains, which enter the nucleus to promote cholesterol synthesis and uptake. When cholesterol in ER membranes exceeds a threshold, the sterol binds to Scap, triggering several conformational changes that prevent the Scap-SREBP complex from leaving the ER. As a result, SREBPs are no longer processed, cholesterol synthesis and uptake are repressed, and cholesterol homeostasis is restored. This review focuses on the four domains of Scap that undergo concerted conformational changes in response to cholesterol binding. The data provide a molecular mechanism for the control of lipids in cell membranes.
Scap 是一种多结构域膜蛋白,作为一种分子机器,可控制哺乳动物细胞中膜的胆固醇含量。自我们实验室发现 Scap 以来的 21 年中,我们已经了解了它如何结合固醇调节元件结合蛋白(SREBPs)并将其从内质网(ER)运输到高尔基体进行蛋白水解加工。蛋白水解会释放 SREBP 转录因子结构域,这些结构域进入细胞核以促进胆固醇合成和摄取。当 ER 膜中的胆固醇超过阈值时,固醇与 Scap 结合,触发几个构象变化,阻止 Scap-SREBP 复合物离开 ER。结果,SREBPs 不再被加工,胆固醇合成和摄取受到抑制,胆固醇稳态得到恢复。这篇综述重点介绍了 Scap 的四个结构域,它们在响应胆固醇结合时会发生协同构象变化。这些数据为细胞膜中脂质的控制提供了分子机制。